摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(4-甲氧基苯基)甲基]-2H-四唑-5-硫酮 | 105219-34-9

中文名称
1-[(4-甲氧基苯基)甲基]-2H-四唑-5-硫酮
中文别名
——
英文名称
1-(4-methoxybenzyl)-1H-tetrazole-5-thiol
英文别名
1-[(4-methoxyphenyl)methyl]-2H-tetrazole-5-thione
1-[(4-甲氧基苯基)甲基]-2H-四唑-5-硫酮化学式
CAS
105219-34-9
化学式
C9H10N4OS
mdl
MFCD00450162
分子量
222.271
InChiKey
DHSRMNZHPIXYOO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    81.3
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-[(4-甲氧基苯基)甲基]-2H-四唑-5-硫酮苯甲醚三氟乙酸 作用下, 反应 2.0h, 以88.2%的产率得到5H-四唑-5-硫醇
    参考文献:
    名称:
    [EN] HINDERED DISULFIDE DRUG CONJUGATES
    [FR] CONJUGUÉS MÉDICAMENTEUX À PONT DISULFURE ENCOMBRÉ
    摘要:
    该发明一般涉及二硫键药物偶联物,其中含有至少一个被至少一个碳氢化合物或取代碳氢化合物所取代的含硫碳原子的连接剂通过二硫键与靶向载体的半胱氨酸硫原子偶联,并且连接剂进一步与药物部分偶联。该发明进一步涉及适合通过二硫键与靶向载体偶联的活化连接剂-药物偶联物。该发明还进一步涉及制备受阻二硫键药物偶联物的方法。
    公开号:
    WO2017064675A1
  • 作为产物:
    描述:
    Methyl N-(4-methoxybenzyl)dithiocarbamate 在 sodium azide 作用下, 以 乙醇 为溶剂, 反应 16.0h, 以71.6%的产率得到1-[(4-甲氧基苯基)甲基]-2H-四唑-5-硫酮
    参考文献:
    名称:
    [EN] HINDERED DISULFIDE DRUG CONJUGATES
    [FR] CONJUGUÉS MÉDICAMENTEUX À PONT DISULFURE ENCOMBRÉ
    摘要:
    该发明一般涉及二硫键药物偶联物,其中含有至少一个被至少一个碳氢化合物或取代碳氢化合物所取代的含硫碳原子的连接剂通过二硫键与靶向载体的半胱氨酸硫原子偶联,并且连接剂进一步与药物部分偶联。该发明进一步涉及适合通过二硫键与靶向载体偶联的活化连接剂-药物偶联物。该发明还进一步涉及制备受阻二硫键药物偶联物的方法。
    公开号:
    WO2017064675A1
点击查看最新优质反应信息

文献信息

  • Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors
    作者:Yiyu Ge、Aslamuzzaman Kazi、Frank Marsilio、Yunting Luo、Sanjula Jain、Wesley Brooks、Kenyon G. Daniel、Wayne C. Guida、Saïd M. Sebti、Harshani R. Lawrence
    DOI:10.1021/jm201118h
    日期:2012.3.8
    guided synthesis of more than 170 derivatives revealed that the thioglycolic acid side chain is required and the carboxylic acid group of this side chain is critical to the CT-L inhibitory activity of compound 1. Furthermore, replacement of the carboxylic acid with carboxylic acid isosteres such as tetrazole or triazole greatly improves potency. Compounds with a thio-tetrazole or thio-triazole side chain
    筛选工作导致鉴定出 PI-8182 ( 1 ),蛋白酶体的胰凝乳蛋白酶样 (CT-L) 活性抑制剂。化合物1含有氢萘醌药效基团,其 2 位为巯基乙酸侧链,4 位为噻吩磺酰胺。开发了一种有效的氢萘醌磺酰胺支架合成路线,并在内部合成了化合物1以确认其结构和活性(IC 50 = 3.0 ± 1.6 μM [ n = 25])。1 的新型氢萘醌衍生物被设计、合成和评估为蛋白酶体抑制剂。超过 170 种衍生物的构效关系 (SAR) 指导合成表明需要巯基乙酸侧链,并且该侧链的羧酸基团对化合物1的 CT-L 抑制活性至关重要。此外,用四唑或三唑等羧酸等排体替代羧酸可大大提高效力。在位置 2 具有硫代四唑或硫代三唑侧链的化合物,其中噻吩被疏水芳基部分取代,是最活跃的化合物,其 CT-L 抑制比化合物1(化合物15e、15f)高 20 倍, 15 小时,图15j,IC 50值在200nM左右,化合物29,IC
  • TRICYCLIC COMPOUND
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP1939205A1
    公开(公告)日:2008-07-02
    The present invention relates to tricyclic compounds each represented by the following formula (I): (wherein, R1, R2, R2', R3, R4, X, Y and Z have the same meanings as defined in the specification); and a drug containing the compound. Since the compounds according to the present invention exhibit an excellent squalene synthetase inhibitory effect and cholesterol synthesis inhibitory effect so that they are useful as a drug such as preventive and/or remedy for diseases in mammals including humans such as hyperlipemia, e.g., hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterolemia and/or arteriosclerosis.
    本发明涉及一种三环化合物,每种化合物由以下式(I)表示:(其中,R1、R2、R2'、R3、R4、X、Y和Z的含义与规范中定义的含义相同);以及含有该化合物的药物。由于根据本发明的化合物表现出优异的角鲨烯合酶抑制作用和胆固醇合成抑制作用,因此它们可用作哺乳动物(包括人类)的疾病预防和/或治疗药物,例如高脂血症,如高胆固醇血症、高甘油三酯血症、低高密度脂蛋白胆固醇血症和/或动脉粥样硬化。
  • Dopamine-.beta.-hydroxylase inhibitors and use thereof
    申请人:Smithkline Beckman Corporation
    公开号:US04707488A1
    公开(公告)日:1987-11-17
    The compounds of this invention are 1-phenylalkyl-2-mercaptotetrazole compounds which are dopamine-.beta.-hydroxylase inhibitors.
    这项发明的化合物是1-苯基烷基-2-巯基四唑化合物,它们是多巴胺-β-羟化酶抑制剂。
  • Process for preparing 1-H-tetrazole-5-thiols
    申请人:American Home Products Corporation
    公开号:US04663461A1
    公开(公告)日:1987-05-05
    A novel process for producing a 1-H-tetrazole-5-thiol of the formula: ##STR1## in which R.sup.1 is hydrogen; lower alkyl; lower alkyl substituted with a carboxylic acid, a carboxylic acid lower alkyl ester, or an hydroxy group; phenyl or phenyl substituted with a halogen, a lower alkyl group, or a lower alkoxy group; benzyl or benzyl substituted with a halogen, a lower alkyl group, or 1-3 alkoxy groups of 1-3 carbon atoms; or trichloroethyl, which process comprises: (a) reacting a sulfinyl or sulfonyl cyanide of the formula: RS(O).sub.n CN in which n is 1 or 2 and R is alkyl; phenyl or phenyl substituted with a halogen, a lower alkyl group, or a lower alkoxy group; benzyl or benzyl substituted on the phenyl ring with a halogen, a lower alkyl group, or a lower alkoxy group; or an alicyclic group, with an azide of the formula R.sup.1 N.sub.5, in which R.sup.1 is as defined above, to form a 5-sulfinyl or sulfonyl-1-H-tetrazole of the formula: ##STR2## in which n is 1 or 2, and R and R.sup.1 are as defined above, and (b) reacting said 5-sulfinyl or sulfonyl-1-H-tetrazole with an alkali metal sulfide or ammonium sulfide.
    一种生产1-H-四唑-5-硫醇的新工艺,其化学式为:##STR1##其中R.sup.1为氢;低碳基;低碳基取代的羧酸、羧酸低碳基酯或羟基;苯基或取代有卤素、低碳基或低碳氧基的苯基;苄基或苄基取代苯环上有卤素、低碳基或1-3个1-3碳原子的低碳氧基;或三氯乙基。该工艺包括:(a)将化学式为RS(O).sub.n CN的亚磺酰基或磺酰基氰化物与化学式为R.sup.1 N.sub.5的叠氮化物反应,其中n为1或2,R为烷基;苯基或取代有卤素、低碳基或低碳氧基的苯基;苄基或苄基取代苯环上有卤素、低碳基或低碳氧基;或脂环基,以形成化学式为:##STR2##其中n为1或2,R和R.sup.1如上所定义,以及(b)将所述5-亚磺酰基或磺酰基-1-H-四唑与碱金属硫化物或铵硫化物反应。
  • Process for preparing 1-H-tetrazole-5-thiols and intermediate compounds
    申请人:American Home Products Corporation
    公开号:US04526978A1
    公开(公告)日:1985-07-02
    A novel process for producing a 1-H-tetrazole-5-thiol of the formula ##STR1## in which R.sup.1 is hydrogen; lower alkyl; lower alkyl substituted with a carboxylic acid, a carboxylic acid lower alkyl ester, or an hydroxy group; phenyl or phenyl substituted with a halogen, a lower alkyl group, or a lower alkoxy group; benzyl or benzyl substituted with a halogen, a lower alkyl group, or 1-3 alkoxy groups of 1-3 carbon atoms; or trichloroethyl, which process comprises: (a) reacting a sulfinyl or sulfonyl cyanide of the formula: RS(O).sub.n CN in which n is 1 or 2 and R is alkyl; phenyl or phenyl substituted with a halogen, a lower alkyl group, or a lower alkoxy group; benzyl or benzyl substituted on the phenyl ring with a halogen, a lower alkyl group, or a lower alkoxy group; or an alicyclic group, with an azide of the formula R.sup.1 N.sub.3, in which R.sup.1 is as defined above, to form a 5-sulfinyl or sulfonyl-1-H-tetrazole of the formula: ##STR2## in which n is 1 or 2, and R and R.sup.1 are as defined above, and (b) reacting said 5-sulfinyl or sulfonyl-1-H-tetrazole with an alkali metal sulfide or ammonium sulfide.
    一种生产式为##STR1##的1-H-四唑-5-硫醇的新工艺,其中R.sup.1为氢;低碳基;低碳基上取代有羧酸、羧酸低碳基酯或羟基;苯基或苯基上取代有卤素、低碳基或低碳基氧基;苄基或苄基上取代有卤素、低碳基或1-3个碳原子的1-3个烷氧基;或三氯乙基。该工艺包括:(a)将式为RS(O).sub.nCN的磺酰基或亚磺酰基氰化物与式为R.sup.1N.sub.3的叠氮化物反应,其中n为1或2,R为烷基;苯基或苯基上取代有卤素、低碳基或低碳基氧基;苄基或苄基在苯基环上取代有卤素、低碳基或低碳基氧基;或脂环族基,以形成式为##STR2##的5-磺酰基或亚磺酰基-1-H-四唑,其中n为1或2,R和R.sup.1如上所定义,以及(b)将所述5-磺酰基或亚磺酰基-1-H-四唑与碱金属硫化物或铵硫化物反应。
查看更多